{"slug":"selank-muscle-loss","verification":{"valid":true,"entries":2,"head":"6ed989cb5141039257553d1c98b279e8e5a6bb8e5e511030c0b3fd0e99797edc"},"energy":{"passes":2,"tokens_in":13019,"tokens_out":3300,"tokens_total":16319,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"6ed989cb5141039257553d1c98b279e8e5a6bb8e5e511030c0b3fd0e99797edc"},"provenance":[{"ts":"2026-06-30T00:41:11.322Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Muscle Loss\nSlug: selank-muscle-loss\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the co","response":"{\n  \"slug\": \"selank-muscle-loss\",\n  \"title\": \"Selank for Muscle Loss: Stress Chemistry, Cortisol, and Repair Pathways\",\n  \"body\": \"## What's breaking down\\nChronic stress elevates cortisol. Sustained high cortisol promotes protein breakdown in muscle tissue and interferes with repair signals. This creates a degeneration layer where catabolism outruns anabolism even if training and protein intake stay consistent. Non-restorative arousal from anxiety or stimulant use can keep the HPA axis active, feeding the same loop. Muscle loss in this context often traces back to neurochemical drivers rather than direct mechanical damage.\\n\\n## Why Selank might help you\\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal keep cortisol elevated and blunt recovery signals.\\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation; it modulates GABA-related systems and influences BDNF expression in preclinical models.\\n3. Therefore for you: If that anxiety/neurochemistry layer is part of your muscle-loss picture, Selank is discussed because it targets repair of the stress response — not because it masks symptoms or directly builds muscle.\\n\\n## How these fit together\\nSingle-compound focus. Selank addresses the anxiety/neurochemistry layer. If your profile includes additional degeneration layers (for example mechanical load or direct anabolic pathways), other compounds would target those separately rather than overlap.\\n\\n## What the evidence actually shows\\nHuman data on Selank come mainly from small Russian trials focused on generalized anxiety disorder. One 2008 trial with 30 patients found effects comparable to low-dose benzodiazepines plus added cognitive benefits. A 2015 study of 70 patients reported better outcomes and fewer side effects when Selank was added to benzodiazepine treatment. No human trials examine Selank for muscle loss, sarcopenia, or cortisol-driven catabolism. (source s3, s","tokens_in":13019,"tokens_out":3300,"cost":0,"prev":"genesis","hash":"7e5272eb853c1d2a64573aac5b91f3fd7d9854a9af29414d8df8a94ce2829608"},{"ts":"2026-07-17T02:41:38.937Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-muscle-loss","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7e5272eb853c1d2a64573aac5b91f3fd7d9854a9af29414d8df8a94ce2829608","hash":"6ed989cb5141039257553d1c98b279e8e5a6bb8e5e511030c0b3fd0e99797edc"}]}